Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
98.20    -0.80 (-0.81%)
Bid:
98.20
Ask:
99.00
Spread: 0.80 (0.815%)
Market Cap: £597.25m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Proposed changes to expense arrangements

24 Nov 2015 10:40

BACIT LIMITED - Proposed changes to expense arrangements

BACIT LIMITED - Proposed changes to expense arrangements

PR Newswire

London, November 24

BACIT LIMITED(a closed-ended investment company incorporated in Guernseywith registration number 55514)

(the "Company")

24 November 2015

Proposed changes to expense arrangements

The Company announces a proposed change to the basis on which the operating expenses of BACIT (UK) Limited, the Company’s investment manager (the “Investment Manager”), are paid with effect from 1 January 2016. The proposed change is subject to shareholder approval. 

The key features of the Company’s investment policy — that it will invest in underlying funds on a “gross return” basis, that it will invest up to one per cent. per annum of its net asset value in drug development projects and that it will donate one per cent. per annum of its net asset value to charities including the Institute for Cancer Research (“ICR”) — will remain unchanged. Both the ICR and the managers of the underlying funds in which the Company currently invests are supportive of the proposed change. 

To date, neither the Investment Manager nor the BACIT investment management team have received a fee from the Company for their investment management services. Under the proposed arrangements, the personnel costs and operating expenses of the investment management function will be covered by a new fee payable by the Company to the Investment Manager equal to 0.19% per annum of the Company’s net asset value. It is not envisaged that the Investment Manager should make a meaningful profit from the fee. Notwithstanding the proposed changes to the expense arrangements Tom Henderson will continue to provide his services as a director of the Company and as CEO of the Investment Manager free of charge. 

A circular, including a notice of an extraordinary general meeting of the Company to approve the proposed changes to the expense arrangements intended to be held at 9.30 a.m. on 11 December 2015 at the offices of Northern Trust International Fund Administration Services (Guernsey) Limited, Trafalgar Court, Les Banques, St Peter Port, Guernsey GY1 3QL will be sent to shareholders shortly. 

A copy of the circular, when published, be available on the Company's website at http://www.bacitltd.com. The Circular will also be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/nsm.

Enquiries:

Northern Trust International Fund Administration Services (Guernsey) Limited

Tel: +44 (0) 1481 745368

Date   Source Headline
18th Jun 202012:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSKemal Malik Appointed as Non-Executive Director
12th Jun 20207:36 amRNSAutolus AUTO1 and AUTO3 data at EHA
11th Jun 20207:00 amRNSFinal Results
29th May 202012:49 pmRNSAutolus presents additional data on AUTO3 in DLBCL
29th May 20207:05 amRNSFirst patient dosed in Achilles’ melanoma study
20th May 20209:24 amRNSNotice of Results
7th May 202012:15 pmRNSAutolus reports Q1 2020 Financial Results
23rd Apr 20207:00 amRNSNew commitment to SwanBio
16th Apr 202012:10 pmRNSAutolus announces acceptance of IND application
31st Mar 20201:26 pmRNSDirector/PDMR Shareholding
26th Mar 20209:41 amRNSStandard form for notification of major holdings
23rd Mar 20207:00 amRNSBusiness Update
20th Mar 20204:44 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20201:53 pmRNSDirector/PDMR Shareholding
5th Mar 202011:14 amRNSDirector/PDMR Shareholding
3rd Mar 202012:29 pmRNSAutolus reports Q4 2019 Financial Results
12th Feb 20202:00 pmRNSFreeline presents clinical data at WORLDSymposium
7th Feb 20201:24 pmRNSFreeline publishes further data for FLT180a
4th Feb 20207:00 amRNSQuarterly Update
30th Jan 202012:08 pmRNSAutolus announces additional data in AUTO3 at EHA
23rd Jan 20207:00 amRNSAutolus announces pricing of public offering
21st Jan 202012:01 pmRNSFreeline to present further FLT180a data at EAHAD
21st Jan 20208:45 amRNSNotice of Capital Markets Day
19th Dec 20197:00 amRNSSyncona makes further $80m commitment to Freeline
9th Dec 20197:00 amRNSAutolus announces new data at ASH Annual Meeting
9th Dec 20197:00 amRNSAutolus announces new data in AUTO3 at ASH
21st Nov 20197:00 amRNSSyncona leads £32 million financing in Azeria
21st Nov 20197:00 amRNSInterim Results
11th Nov 20199:00 amRNSNotice of Results
7th Nov 201912:32 pmRNSAutolus reports Q3 2019 Financial Results
6th Nov 20192:20 pmRNSAutolus to Present New Data at the ASH Meeting
6th Nov 20192:13 pmRNSFreeline presents pre-clinical data at ASH meeting
3rd Sep 20197:00 amRNSSyncona cornerstones £100m financing in Achilles
3rd Sep 20197:00 amRNSSyncona makes £48 million commitment to Gyroscope
12th Aug 20197:00 amRNSQuarterly Update
8th Aug 201912:59 pmRNSAutolus reports Q2 2019 Financial Results
1st Aug 20197:00 amRNSCompletion of sale of Blue Earth Diagnostics
31st Jul 201912:24 pmRNSTotal Voting Rights
30th Jul 201911:55 amRNSResult of AGM
18th Jul 20193:51 pmRNSIssue of shares per 2019 dividend & PDMR dealings
11th Jul 201911:21 amRNSIssue of shares pursuant to LTIP and PDMR dealings
8th Jul 20197:00 amRNSFreeline provides 12 month Haemophilia B data
28th Jun 201912:33 pmRNS2019 Dividend Scrip Reference Price
27th Jun 201911:44 amRNSPublication of Annual Report and Notice of AGM
27th Jun 20197:00 amRNSSale of Blue Earth Diagnostics to Bracco Imaging
21st Jun 20194:18 pmRNSDirector Information
13th Jun 20192:27 pmRNSDividend Announcement
13th Jun 20197:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.